announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trials for its Multiplo ® Complete Syphilis (TP/nTP) Antibody Test (Multiplo ® TP/nTP ...

HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical ...

HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical ...

Halifax, Nova Scotia, 9 January, 2025 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trials ...

MedMira Inc. has received investigational testing authorization from Health Canada to commence clinical trials for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test. This innovative test ...

announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trials for its Multiplo ® Complete Syphilis (TP/nTP) Antibody Test (Multiplo ® TP/nTP ...

At-home test kits offer a convenient way to monitor health conditions privately, using advanced technologies for accurate and ...